Rare Disease Therapeutics, Inc. is America’s first exclusively orphan drug company committed to developing and marketing drugs for rare disorders. RDT is dedicated to patients with unmet medical needs that have been overlooked by other pharmaceutical companies. RDT distributes Orfadin® (nitisinone) for Hereditary Tyrosinemia Type I and Cystadane® (betaine anhydrous for oral solution) for Homocystinuria.
THERAPEUTICS Biopharmaceuticals Pharmaceuticals
Copyright 2013-14 © a2z, Inc. All rights reserved.